Kothari Fermentation board to meet on May 29
Kothari Fermentation & Biochem Ltd. will hold a board meeting on May 29, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window is closed until 48 hours after the results are declared.

*this image is generated using AI for illustrative purposes only.
Kothari Fermentation & Biochem Ltd. has announced that its board of directors will meet on Friday, May 29, 2026. The primary agenda of the meeting is to consider and approve the audited financial results of the company for the quarter and fiscal year ended March 31, 2026. The meeting is being convened in compliance with Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Closure of Trading Window
In accordance with the company's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities remains closed. This restriction applies to all designated persons and their immediate relatives. The window will reopen 48 hours after the declaration of the audited financial results for the period ending March 31, 2026. The company had previously communicated this closure via a notice dated March 24, 2026.
Meeting Details
The board meeting will address the financial performance for the fourth quarter and the full financial year 2025-26. Along with the financial results, the board may also take up other business items as necessary during the session.
| Event | Details |
|---|---|
| Board Meeting Date | May 29, 2026 |
| Financial Period | Quarter and Year ended March 31, 2026 |
| Trading Window Status | Closed till 48 hours post-result declaration |
| Regulatory Reference | SEBI (LODR) Regulations, 2015 |
Historical Stock Returns for Kothari Fermentation & Biochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.49% | +0.76% | -4.67% | -7.96% | -49.49% | -39.44% |
How might Kothari Fermentation & Biochem's FY2025-26 revenue and profitability compare to the previous fiscal year, and what key growth drivers could influence investor sentiment post-results?
Will the board consider announcing dividends or any capital allocation decisions alongside the audited financial results on May 29, 2026?
How could the company's financial performance for FY2025-26 reflect broader trends in India's fermentation and biochemicals sector, particularly amid evolving demand for bio-based products?


































